ORPHA:1762
Proximal Xq28 duplication syndrome
Also known as: MECP2 duplication syndrome · X-linked intellectual disability syndrome, Lubs type
Publications
17,370
Trials
2
Interventional, condition-specific
Researchers
1,149
Distinct authors in sample
Gene link
MECP2
Definitive
Readiness
6/6
Stages with a signal
Clinical definition (Orphanet)
A rare X-linked genomic disorder associated with interstitial chromosomal duplications at Xq28 encompassing the MECP2 gene. It is characterized in males by onset , severe global , , spasticity, , gastrointestinal symptoms and recurrent respiratory infections. In females, the is more variable.
How rare: How common this is has not been clearly measured.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0010283
- MeSH:C537723
- OMIM:300260
- UMLS:C1846058
- NCIT:C126747
Additional Mondo synonyms (11)
Lubs X-linked intellectual disability syndrome · Lubs X-linked mental retardation syndrome · MRXSL · Xq28 (MECP2) duplication · distal duplication Xq · intellectual developmental disorder, X-linked syndromic, Lubs type, X-linked recessive · intellectual disability, X-linked, syndromic, Lubs type · intellectual disability, X-linked, with recurrent respiratory infections · mental retardation, X-linked, with recurrent respiratory infections · syndromic X-linked intellectual disability Lubs type · telomeric duplication Xq
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
6/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedPresent
Definitive — MECP2
- LiteraturePresent
17,370 matched papers (10,311 in last 10 years) Source
- Phenotype characterisedPresent
126 HPO annotations (e.g. Hypoplasia of the maxilla; Deeply set eye; Dental crowding) Source
- Animal modelPresent
4 genotype models (Mus musculus) Source
- Orphan designationPartial
2 EMA designations (none yet with FDA orphan-indication approval) — e.g. adeno-associated virus serotype 9 containing CRISPR/Cas13Y and guide RNA against the human MECP2 gene Source
- Interventional trialPresent
2 matched on ClinicalTrials.gov (2 recruiting in sample)
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Yes — we know a specific gene responsible (MECP2).
GenCC classification: Definitive.
Phenotypes (Monarch / HPO)
126
Associated phenotypes · MONDO:0010283
- Hypoplasia of the maxilla
- Deeply set eye
- Dental crowding
- Aggressive behavior
- Autistic behavior
Showing 5 of 126 — open Monarch for the full list.
Animal models (Monarch / Alliance)
4
Model associations linked to this Mondo ID
- Tg(MECP2)3Hzo/0 [background:] either: (FVB/N x 129S6/SvEvTac)F1 or (FVB/N x C57BL/6J)F1·MGI:5314412·Mus musculus
- Mapttm1(Mecp2)Jae/Mapttm1(Mecp2)Jae [background:] B6.Cg-Mapttm1(Mecp2)Jae·MGI:5318976·Mus musculus
- Tg(MECP2)1Hzo/0 [background:] either: (FVB/N x 129S6/SvEvTac)F1 or (FVB/N x C57BL/6J)F1·MGI:5314411·Mus musculus
- Tg(MECP2)1Hzo/0 [background:] FVB-Tg(MECP2)1Hzo/J·MGI:6305084·Mus musculus
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
2
Designations · no FDA orphan-indication approval yet
- EMA adeno-associated virus serotype 9 containing CRISPR/Cas13Y and guide RNA against the human MECP2 geneTreatment of MECP2 duplication syndrome · 24/05/2024 · PositiveEMA designation
- EMA 2'-O-(2-Methoxyethyl) modified antisense oligonucleotide against MECP2 pre-mRNATreatment of MECP2 duplication syndrome · 21/11/2025 · PositiveEMA designation
Sources: FDA OOPD · EMA orphan designations
Open Targets candidates
No drugs or clinical candidates returned for this Mondo ID on Open Targets.
CTD chemicals (MyDisease.info)
No CTD chemical associations returned for this Mondo ID.
Literature
Is anyone studying this?
17,370
17,370 papers — among the better-studied rare conditions, though still a fraction of common-disease literature (breast cancer: over 700,000). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
17,370 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
10,311 in the last 10 years · low confidence
Phrase hits: 728 · MeSH hits: 1
Who's working on it?
1,149
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Suter B18 papers · 2025
Department of Pediatrics, Baylor College of Medicine, Houston, Texas.
Papers in Europe PMC - 02Pehlivan D14 papers · 2025
Department of Molecular and Human Genetics, Baylor College of Medicine, Texas, USA; Section of Neurology, Department of Pediatrics, Baylor College of Medicine, Texas, USA.
Papers in Europe PMC - 03Zoghbi HY11 papers · 2026
Department of Human and Molecular Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Papers in Europe PMC - 04Glaze DG9 papers · 2025
Department of Pediatrics, Baylor College of Medicine, Houston, Texas.
Papers in Europe PMC - 05Neul JL8 papers · 2025
Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.
Papers in Europe PMC - 06Wang J8 papers · 2025
Department of Ophthalmology, Baylor College of Medicine, Houston, Texas 77030.
Papers in Europe PMC - 07Carvalho CMB7 papers · 2026
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA; Pacific Northwest Research Institute, Seattle, WA, USA.
Papers in Europe PMC - 08Downs J7 papers · 2026
Centre for Child Health Research, The Kids Research Institute Australia, The University of Western Australia, Perth, Western Australia, Australia.
Papers in Europe PMC - 09Leonard H7 papers · 2026
Centre for Child Health Research, The Kids Research Institute Australia, The University of Western Australia, Perth, Western Australia, Australia.
Papers in Europe PMC - 10Marsh ED7 papers · 2025
Division of Child Neurology, Departments of Neurology and Pediatrics, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
2
interventional trials for this specific condition
2 interventional trials matched this specific condition name; 2 currently recruiting in our sample.
Data as of 11 September 2026 · last trial check 28 July 2026
2 interventional trials — more than 77.2% of diseases in the trials denominator have none at all (5501 of 7126; this disease is at the 84.5th percentile).
low confidence · 84.5th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
2 interventional trials matched after quoted-phrase search and title/condition post-filter.
- NCT06430385·RECRUITING·ATTUNE: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intrathecally-Administered ION440 in Participants With Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome (MDS)
Not reviewed·Conditions: Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome·Matched via name phrase
- NCT06615206·RECRUITING·A First-in-Human Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of a Novel CRISPR RNA-editing Therapy in Patients with Mecp2 Duplication Syndrome, a Rare Orphan Disease (HERO)
Not reviewed·Conditions: MECP2 Duplication Syndrome·Matched via name phrase
Observational and natural-history studies
2 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
None of the matched observational studies is currently listed as recruiting.
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 1 · after dedupe 1 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 1 · dropped 0 · fetched 2026-07-29
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Uncertain / not reviewed (1)
- ctis·2023-507192-22-00·Authorised, recruiting·ION440-CS1: A Phase 1-2, Double-Blind, Sham-Controlled Multiple Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intrathecally-Administered ION440 in Patients with MECP2 Duplication Syndrome
skipped — LLM skipped (--skip-llm)
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Proximal Xq28 duplication syndrome — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
("Proximal Xq28 duplication syndrome" OR "MECP2 duplication syndrome" OR "X-linked intellectual disability syndrome, Lubs type" OR "Lubs X-linked intellectual disability syndrome" OR "Lubs X-linked mental retardation syndrome" OR "MRXSL" OR "Xq28 (MECP2) duplication" OR "distal duplication Xq" OR "intellectual developmental disorder, X-linked syndromic, Lubs type, X-linked recessive" OR "intellectual disability, X-linked, syndromic, Lubs type" OR "intellectual disability, X-linked, with recurrent respiratory infections" OR "mental retardation, X-linked, with recurrent respiratory infections" OR "syndromic X-linked intellectual disability Lubs type" OR "telomeric duplication Xq") OR (MESH:"Lubs X-linked mental retardation syndrome") OR ("MECP2" OR "MECP2 syndrome" OR "MECP2-related")MeSH descriptor terms unioned into the query: Lubs X-linked mental retardation syndrome
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Proximal Xq28 duplication syndrome" OR "MECP2 duplication syndrome" OR "X-linked intellectual disability syndrome, Lubs type" OR "Lubs X-linked intellectual disability syndrome" OR "Lubs X-linked mental retardation syndrome" OR "MRXSL" OR "Xq28 (MECP2) duplication" OR "distal duplication Xq" OR "intellectual developmental disorder, X-linked syndromic, Lubs type, X-linked recessive" OR "intellectual disability, X-linked, syndromic, Lubs type" OR "intellectual disability, X-linked, with recurrent respiratory infections" OR "mental retardation, X-linked, with recurrent respiratory infections" OR "syndromic X-linked intellectual disability Lubs type" OR "telomeric duplication Xq"
Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 2 interventional · 2 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: ok — strategies attempted: phrase, mesh; with hits: phrase, mesh
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
- Publication count (17370) is extremely high with unknown/missing prevalence — treat as possible over-matching, not proven research intensity
Ingested 2026-07-26T18:04:48.183Z
